The partnership will provide six MRC clinical fellows with industry placement opportunities
Category: News
Currently the third most common cancer in the UK, lung cancer affects 40,000 people annually
The nanocage technology combines both mRNA and traditional virus-based vaccines to create virus-like efficacious vaccines
The funding aims to reduce health inequalities in these groups and save more lives
The network will support the development, evaluation and adoption of innovative health and care technology
Globally affecting 4% of the population, autoimmune diseases mistakenly attack healthy cells, tissues and organs in the body
Both drugs have the potential to offer a disease-modifying approach to the lung disease
Areas include health research across life stages, from paediatrics to health ageing and resilience
Spread through Anopheles mosquitoes, the disease affected around 249 million people globally in 2022
The cardiovascular disease, pulmonary arterial hypertension, affects around 6,500 people in the UK